DNAPRINT GENOMICS, INC.. (OTCBB: DNAG) was up 8.97% this morning in early trading.
DNAPrint Genomics, Inc. develops genomics-based products and services that focus on the drug development, pharmacogenomic diagnostic tests, and forensics technology and consumer genetic tests. Its primary product is PT-401, a >Super EPO= (erythropoietin) dimer protein drug for treatment of anemia in renal dialysis patients. The company=s other products under development include PT-401, which would be targeted to patients with a genetic profile indicating their propensity; OVANOME, a genomic-based diagnostic tool that matches ovarian cancer patients with the suitable form and dose of chemotherapy; and STATINOME, a test for the cardiac drug market to determine whether patients would be good or poor responders to statins. DNAPrint also offers ANCESTRYbyDNA and EURO-DNA, both are genome-based tests that determine genetic heritage; DNAWitness, which enables forensics experts in the law enforcement field to determine genetic heritage from DNA samples obtained from crime scenes; and RETINONE, another forensics product that can infer human iris (eye) color from DNA samples
-------------------- Trading is a blast!! Posts: 4921 | From: Rhode Island | Registered: May 2005
| IP: Logged |
I'm playing it. I wonder if it's done going down yet. Seems like a company with a lot going for it. Nice little up move today.
Posts: 344 | From: Berkeley, CA | Registered: Sep 2005
| IP: Logged |